ProfileGDS4459 / ENSG00000196976
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 70% 28% 60% 50% 55% 58% 52% 53% 53% 51% 52% 50% 49% 50% 53% 54% 63% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.2370
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.7328
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.8260
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.550
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.5755
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.6858
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.5352
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.4953
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.5253
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.4651
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.3552
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.3650
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.3749
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.4350
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.5153
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.5454
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8463